Try our Advanced Search for more refined results
March 25, 2016
RHODES PHARMACEUTICALS L.P. v. ACTAVIS, INC. et al
Case Number:
2:16-cv-01668
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 28, 2016
Allergan Faces NJ Patent Suit Over Generic ADHD Medication
Rhodes Pharmaceuticals LP on Friday challenged Allergan PLC's request for approval of a generic version of attention deficit hyperactivity disorder medication Aptensio XR, contending in a New Jersey federal court suit that the pharmaceutical giant is violating a number of the company's patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login